Immunic Inc. (NASDAQ: IMUX) closed the day trading at $1.76 up 7.32% from the previous closing price of $1.64. In other words, the price has increased by $+0.1200 from its previous closing price. On the day, 584699 shares were traded. IMUX stock price reached its highest trading level at $1.7900 during the session, while it also had its lowest trading level at $1.6150.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
For a better understanding of IMUX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.60 and its Current Ratio is at 9.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
On April 15, 2021, Aegis Capital started tracking the stock assigning a Buy rating and target price of $55.Aegis Capital initiated its Buy rating on April 15, 2021, with a $55 target price.
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 14 when Neermann Joerg bought 47,000 shares for $1.26 per share. The transaction valued at 59,032 led to the insider holds 100,000 shares of the business.
Neermann Joerg bought 35,000 shares of IMUX for $43,610 on Dec 13. The Director now owns 53,000 shares after completing the transaction at $1.25 per share. On Nov 23, another insider, Neermann Joerg, who serves as the Director of the company, bought 18,000 shares for $1.39 each. As a result, the insider paid 25,020 and bolstered with 18,000 shares of the company.
Stock Price History:
Over the past 52 weeks, IMUX has reached a high of $12.64, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 1.9272, while the 200-Day Moving Average is calculated to be 3.1310.
Over the past 3-months, IMUX traded about 1.06M shares per day on average, while over the past 10 days, IMUX traded about 1.08M shares per day. A total of 38.31M shares are outstanding, with a floating share count of 31.08M. Insiders hold about 0.10% of the company’s shares, while institutions hold 44.70% stake in the company. Shares short for IMUX as of Jan 30, 2023 were 5.97M with a Short Ratio of 5.62M, compared to 7.07M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 13.45% and a Short% of Float of 13.66%.
Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.73 for the current quarter, with a high estimate of -$0.39 and a low estimate of -$1.39, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.38 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$2.54 and -$3.69 for the fiscal current year, implying an average EPS of -$2.9. EPS for the following year is -$2.1, with 4 analysts recommending between -$1.53 and -$3.22.